PDF
Cite
Share

facebook

twitter

google

linkedin

Volume 42 Issue 7

Jul. 2026

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2026 > 42(7): 1541-1550

Guidelines on the prevention and treatment of hepatitis B virus reactivation in high-risk populations in China (Version 2026)

DOI: 10.12449/JCH260709

Received Date: 2026-03-18
Accepted Date: 2026-06-15
Published Date: 2026-07-25

Abstract

In the context of immunosuppression， high-risk populations may develop hepatitis B virus （HBV） reactivation， leading to active hepatitis and even liver failure， which poses a threat to life. The initiation timing of prophylactic anti-HBV therapy is a frequent clinical challenge. This guideline aims to provide evidence-based practice recommendations for the management of HBV reactivation in high-risk populations in China.
- Hepatitis B,
- Virus Activation,
- Practice Guidelines,
- China

References

Relative Articles

Supplements

中国高危人群乙型肝炎病毒再激活防治指南（2026 年版）参考文献.pdf

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (147) PDF downloads(63)

Proportional views

Related

The first journal specializing in hepatobiliary and pancreatic diseases in China

Supervisor：Ministry of Education of the People's Republic of China

Sponsor：Jilin University

Academic Support: Chinese Society of Hepatology，Chinese Medical Association

Address: 461 Xinjiang Road, Changchun

Submit：0431-88782044

Peer review：0431-88783542

Email：lcgdb@vip.163.com

YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd

/

DownLoad: Full-Size Img PowerPoint